ICNMD 2024

Sponsorship & Exhibits

ICNMD is an excellent opportunity to interact with a diverse group of clinicians, scientists, students, and industry professionals involved with muscular dystrophies, other myopathies, myasthenia gravis, polyneuropathies, spinal cord disorders, and neurofibromatosis, to list only a few. Over 1,000 clinicians and scientists from around the world are expected to attend.

Increase your visibility and organization’s exposure to national and international markets by becoming a sponsor and/or exhibitor or by holding an industry-supported symposium at this outstanding and important Congress.

Please see below for background information and for the link to request our sponsorship brochure.

The Congress is pleased to offer a variety of options, including but not limited to:

  • Industry-supported seminars
  • Print, digital and onsite advertising opportunities
  • Exhibit booths
  • and more…

To receive more details on how to sponsor, and/or exhibit at, our event, please fill out our Contact Form here.

Statistics on Current and Past Editions

Event Attendance

YearVenueAttendanceYearVenueAttendance
2024Perth, Australia 1,000 exp.2014Nice, France900
2022Brussels, Belgium1,2502010Naples, Italy800
2021Virtual, Worldwide1,3502006Istanbul, Turkey1,500
2018Vienna, Austria1,4002002Vancouver, Canada900
2016Toronto, Canada8001998Adelaide, Australia1,200

Demographics & Statistics

Regional statistics from past ICNMD editions:

ICNMD 2022
(Belgium, Europe)
ICNMD 2021
(virtual, worldwide)
ICNMD 2018
(Austria, Europe)
ICNMD 2016
(Canada, North America)
  • Europe 74%
  • North America 15%
  • Asia 5%
  • Latin America 4%
  • Middle East & Africa 2%
  • Europe 59%
  • North America 20%
  • Latin America 8%
  • Asia 8%
  • Middle East & Africa 5%
  • Europe 66%
  • North America 17%
  • Asia 11%
  • Middle East & Africa 4%
  • Latin America 2%
  • North America 66%
  • Europe 19%
  • Asia 9%
  • Middle East & Africa 3%
  • Latin America 3%

Category statistics from past ICNMD editions:

ICNMD 2022
(Belgium, Europe)
ICNMD 2021
(virtual, worldwide)
ICNMD 2018
(Austria, Europe)
ICNMD 2016
(Canada, North America)
  • Healthcare Professionals 47%
  • Industry 37%
  • Academics (non HCP) 7%
  • Patient Organizations 1%
  • Other 8%
  • Healthcare Professionals 36%
  • Industry 31%
  • Academics * 31%
  • Patient Organizations 1%
  • Other 1%
  • Healthcare Professionals 36%
  • Industry 33%
  • Academics * 23%
  • Patient organizations 1%
  • Other 8%
  • Healthcare Professionals 40%
  • Industry 33%
  • Academics * 12%
  • Patient organizations 7%
  • Other 7%

* Some (most) of which are HCP

  • Akashi Therapeutics
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amylyx Pharmaceuticals
  • Apellis Pharmaceuticals
  • argenx
  • Astellas Gene Therapies
  • Augustine Therapeutics
  • Biogen
  • Cerevel Therapeutics
  • BioMarin Pharmaceutical
  • Canon/Toshiba Medical Systems
  • CSL Behring
  • Dyne Therapeutics
  • Fulcrum Therapeutics
  • GE Healthcare
  • Genea Biocells
  • GeneDx
  • Grifols
  • Grupo Ferrer
  • Healx
  • Idera Pharmaceuticals
  • Italfarmaco
  • iThera Medical
  • Janssen Pharmaceutical
  • Journal of Neuromuscular Diseases
  • LFB Biomedicaments
  • LifeLabs Genetics
  • Lupin Neurosciences
  • MGZ – Medical Genetics Center
  • Novartis Gene Therapies
  • Octapharma
  • Pharnext
  • Pfizer
  • Philips Healthcare
  • PTC Therapeutics
  • Roche
  • Sanofi Genzyme
  • Santhera Pharmaceuticals
  • Sarepta Therapeutics
  • Scholar Rock
  • SERB
  • Takeda Pharmaceuticals
  • Terumo BCT
  • UCB Biopharma
  • Ultragenyx Pharmaceutical
 

Contact Us

Please contact our dedicated Sponsorship & Exhibits Sales Manager for more information on our sponsorship and exhibits options, and to start discussing how you would like to support and be involved in ICNMD.

Mrs. Cali (Carine) Vindeirinho
Senior Sponsorship & Exhibits Sales Manager
ICNMD-Sponsorship(at)icsevents.com
Direct: [+1] 604 639 3919
Office: [+1] 604 681 2153 x 138